Perfect Medical Enterprises Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 31-07-2024
- Paid Up Capital ₹ 1.92 M
as on 31-07-2024
- Company Age 23 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 11.12 Cr
as on 31-07-2024
- Revenue 5.31%
(FY 2023)
- Profit -6.20%
(FY 2023)
- Ebitda 3.99%
(FY 2023)
- Net Worth 7.57%
(FY 2023)
- Total Assets 24.77%
(FY 2023)
About Perfect Medical Enterprises
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.92 M.
The company has closed loans amounting to ₹11.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krupa Senthil and Senthil Sengottaiyan serve as directors at the Company.
- CIN/LLPIN
U51397TN2001PTC048060
- Company No.
048060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2001
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Perfect Medical Enterprises?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krupa Senthil  | Director | 15-Feb-2016 | Current |
| Senthil Sengottaiyan | Director | 08-Jun-2017 | Current |
Financial Performance of Perfect Medical Enterprises.
Perfect Medical Enterprises Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.31% increase. The company also saw a slight decrease in profitability, with a 6.2% decrease in profit. The company's net worth moved up by a moderate rise of 7.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perfect Medical Enterprises?
In 2023, Perfect Medical Enterprises had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Mar 2016 | ₹7.00 M | Satisfied |
The South Indian Bank Limited Creation Date: 25 Aug 2014 | ₹7.00 M | Satisfied |
Canara Bank Creation Date: 02 Apr 2011 | ₹3.11 Cr | Satisfied |
How Many Employees Work at Perfect Medical Enterprises?
Perfect Medical Enterprises has a workforce of 22 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perfect Medical Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perfect Medical Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
